Search

everythinglearnresearchcommunity

for

Search:↓

Cancer treatments targeting specific cells and the immune system can cause skin, mouth, hair, and nail problems, affecting patients' quality of life and treatment adherence.

WNT10A helps esophageal cancer cells spread and keep renewing themselves.

Oral mTOR inhibitors often cause skin and hair side effects but usually don't require stopping treatment.

A cancer drug called nilotinib might cause hair loss due to inflammation around hair follicles.

The congress highlighted new gene therapy techniques and cell transplantation methods for treating diseases.

Keratinocyte stem cells are crucial for skin renewal and have potential in wound healing and tissue regeneration.

LIPH mutations cause woolly hair in some Chinese people.

Differences in growth factors in platelet-rich plasma therapy for hair loss can vary between patients and can be influenced by the devices used, possibly leading to inconsistent results.

Hair follicle development is controlled by interactions between skin tissues and specific molecular signals.

BAY 43-9006 helps control kidney cancer growth but doesn't significantly increase overall survival.

Activating TRPV3 stops human hair growth.

YAP and TAZ proteins are necessary for the development of two types of skin cancer.

Early recognition and management of skin side effects from new cancer therapies can prevent treatment delays.

Stem cells compete for space using cell adhesion, and mutations can affect their competitive success, with implications for tissue health and disease.

Spironolactone may make some cancer treatments more effective by blocking a protein that helps cancer cells survive.

Growth factors are crucial for hair follicle growth and development.

Multiomics helps understand and improve skin healing and repair.

Targeting the protein Caveolin-1 might help treat a type of scarring hair loss called Frontal Fibrosing Alopecia.

Inhibiting AP-1 changes skin tumor types and affects tumor cell identity.

Inhibiting AP-1 changes skin tumor types and affects tumor cell identity.

Excessive eyelash growth from erlotinib may indicate positive tumor response and help treat madarosis.

TRPV3 could be a target for treating pain, skin disorders, and hair problems, but more research is needed to create effective drugs.

Hair follicle growth and development are controlled by specific genes and molecular signals.

Hair follicle stem cells use specific chromatin changes to control their growth and differentiation.

Estrogen therapy can reduce skin aging but has cancer risks.

Cepharanthine is a well-tolerated drug with multiple medical uses, including anti-inflammatory and anti-cancer properties.

Understanding how cells die in the skin is important for treating skin diseases and preventing hair loss.

Vitamin D has potential benefits for cancer prevention, heart health, diabetes, obesity, muscle function, skin health, and immune function, but clinical results are mixed and more research is needed.

A certain smell receptor in hair follicles can affect hair growth when activated by a synthetic sandalwood scent.

Acne is caused by genetics, diet, hormones, and bacteria, with treatments not yet curative.